Global Lower Extremities Market 2017-2021
About Lower Extremities
The term extremity is used to refer to a person's limbs and their various parts. The lower extremities include foot, toes, ankles, knees, and thighs. The extremity products are used to treat, repair, replace, or heal extremity injuries such as fractures and damage. These products include external recovery braces, surgical implants, joint replacements, biologics, and external support implants. The braces and supporting systems will drive the overall growth of the market owing to the increasing number of primary knee and hip arthroplasty procedures and revision procedures. The extremity market is a part of the orthopedic devices market and will be the fastest-growing segment of the market during the forecast period.
Technavio’s analysts forecast the global lower extremities market to grow at a CAGR of 7.66% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global lower extremities market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various types of products that are used for treatment purposes.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Lower Extremities Market 2017-2021
Technavio recognizes the following companies as the key players in the global lower extremities market: DePuy Synthes, Stryker, and Zimmer Biomet.
Other Prominent Vendors in the market are: Active Implants, Acumed, Arthrex, Avitus Orthopaedics, Biotech Limb and Brace, Bioventus, Bone Therapeutics, Bone Biologics, Ceramisys, ConforMIS, CONMED, CollPlant, DJO Global, Evolutis, Exactech, FH Orthopedics, Graftys, ICONACY Orthopedic Implants, Integra LifeSciences, implantcast, Isto Biologics , Lima Corporate, Medtronic, Merete Group, Össur, OsteoMed, Orthofix, Orthogem, Promedics Orthopaedic, Regenexx,, RTI Surgical, Sigma Graft, Silver Bullet Therapeutics, Skye Biologics, Smith & Nephew, Stanmore Implants Worldwide, Surgical Appliance Industries, Wright Medical Group, and Xtant Medical.
Commenting on the report, an analyst from Technavio’s team said: “One trend in market is growing popularity of MI procedures. Traditional open surgeries can cause post-operation complications such as pain, partially collapsed lungs, blood clots, fatigue, muscle atrophy, and infections. The anesthesia administered before surgeries can cause nausea, sore throat, confusion, and sleepiness. To reduce such complications, medical facilities have started implementing MI techniques in their surgical procedures.”
According to the report, one driver in market is hip replacement procedures in UK. The joint replacement surgeries such as hip and knee replacement and revision procedures are increasing the need for lower extremity products in the market. For the replacement procedure, artificial implants are used, which replaces the joints in hip and knees. In 2002, the National Joint Registry was set up by the Department of Health and Welsh Government, UK. The registry collects the orthopedic reconstruction data from the NHS and procedures performed in the NHS hospitals. According to the National Joint Registry, the number of revision hip replacement procedures performed in 2014 and 2015 were 8,176 and 7,214, respectively. For hip replacement revision cases, a dip in the number of cases was observed in 2015 owing to the increased use of advanced lower extremity products.
Further, the report states that one challenges in market is high procedure cost. Hospitals and surgical centers are under constant pressure to deliver quality care at low cost. However, this has become difficult due to the implementation of advanced procedures that involve the use of sophisticated devices. Hospitals and ASCs need to consider various procurement processes and budget allocation considerations before purchasing such devices. To increase their budget, hospitals sometimes implement the procedure cost, which can be high for the individuals. It increases cost burden on them, which hinders the market adoption. High procedure cost can impact the market growth negatively.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- https://www.technavio.com/report/global-orthopedics-and-general-medical-devices-global-lower-extremities-market-2017-2021
DePuy Synthes, Stryker, Zimmer Biomet, Active Implants, Acumed, Arthrex, Avitus Orthopaedics, Biotech Limb and Brace, Bioventus, Bone Therapeutics, Bone Biologics, Ceramisys, ConforMIS, CONMED, CollPlant, DJO Global, Evolutis, Exactech, FH Orthopedics, Graftys, ICONACY Orthopedic Implants, Integra LifeSciences, implantcast, Isto Biologics , Lima Corporate, Medtronic, Merete Group, Össur, OsteoMed, Orthofix, Orthogem, Promedics Orthopaedic, Regenexx,, RTI Surgical, Sigma Graft, Silver Bullet Therapeutics, Skye Biologics, Smith & Nephew, Stanmore Implants Worldwide, Surgical Appliance Industries, Wright Medical Group, and Xtant Medical.